ReShape Lifesciences Inc. (RSLS)
NASDAQ: RSLS · Real-Time Price · USD
4.380
-0.020 (-0.45%)
Dec 20, 2024, 4:00 PM EST - Market closed
ReShape Lifesciences Market Cap
ReShape Lifesciences has a market cap or net worth of $3.12 million as of December 20, 2024. Its market cap has decreased by -35.17% in one year.
Market Cap
3.12M
Enterprise Value
2.57M
1-Year Change
-35.17%
Ranking
Category
Stock Price
$4.38
Market Cap Chart
Since August 22, 2018, ReShape Lifesciences's market cap has decreased from $3.45M to $3.12M, a decrease of -9.58%. That is a compound annual growth rate of -1.58%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Azitra | 3.16M |
| NLS Pharmaceutics AG | 3.16M |
| InMed Pharmaceuticals | 3.16M |
| Lipella Pharmaceuticals | 3.16M |
| Alaunos Therapeutics | 3.14M |
| Titan Pharmaceuticals | 3.09M |
| Tharimmune | 3.08M |
| Artelo Biosciences | 3.06M |